Realm Therapeutics plc

www.realmtx.com TICKER: RLM     EXCHANGE: AIM

Realm Therapeutics is an emerging specialty bio-pharmaceutical company developing therapeutic products to treat immune related disorders in adults and children, using its proprietary hypochlorous acid-based technology. 

LATEST REPORTS

 
Realm Therapeutics plc - Equity Development Investor Forum, January 2017
Published: Jan 27 2017

Alex Martin, Chief Executive Officer, explains the strategy behind Realm Therapeutics.

REGISTER / LOGIN TO VIEW THIS RESEARCH IN FULL

 
A New Realm of Opportunity
Published: Jan 19 2017

Realm Therapeutics (RLM) is an emerging specialty bio-pharmaceutical company developing therapeutic products to treat immune related disorders in adults and children, using its proprietary hypochlorous acid-based technology. RLM (formerly PuriCore plc) is now a focused entity, having divested its non-strategic supermarket retail business for $13.5m to Chemstar Corp in October 2016.RLM is preparing to take its pipeline of novel pharmaceutical therapies, which hinges on patented high concentration formulations of hypochlorous acid, into Phase II studies during 2017. RLM will tackle unmet need fo

REGISTER / LOGIN TO VIEW THIS RESEARCH IN FULL

ARCHIVE